141W94,
Agenerase,
amprenavir,
tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate,
Vertex VX478,
VX 478,
VX-478,
amprenavir,
161814-49-9,
Agenerase,
Prozei,
VX-478,
141W94,
Vertex VX478,
Amprenavir (agenerase),
KVX-478,
VX 478,
DRG-0258,
UNII-5S0W860XNR,
Vertex,
C25H35N3O6S,
CHEBI:40050,
HSDB 7157,
Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate,
5S0W860XNR,
(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate,
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate,
{3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER,
AMV,
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester,
141 W94,
(3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate,
(3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate,
Amprenavir [USAN],
angenerase,
amprenavir[usan],
Agenerase (TM),
Agenerase (TN),
(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate,
(S)-tetrahydrofuran-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate,
[(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate,
Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-,
GNA & Amprenavir,
HHA & Amprenavir,
Amprenavirum,
Amprenavir (JAN/USAN/INN),
Amprenavir [USAN:INN:BAN],
1hpv,
3ekp,
3ekv,
3nuj,
3nuo,
VX478,
NCGC00159461-02,
AK-83503,
Amprenavir-(Agenerase),
PubChem18308,
1t7j,
3nu3,
3nu4,
3nu5,
3nu6,
3nu9,
3sm2,
APV & AAG,
APV & HSA,
CHEMBL116,
AC1L22EW,
AC1Q5X5K,
SCHEMBL34151,
MLS006011492,
BIDD:GT0398,
Amprenavir & human serum albumin,
3s43,
3s45,
YMARZQAQMVYCKC-OEMFJLHTSA-N,
HMS2090N10,
KS-00000L2H,
ZINC3809192,
AN-502,
BDBM50215393,
MFCD00934214,
s1639,
Amprenavir & alpha1-acid glycoprotein,
AKOS000280844,
AM84544,
API0001480,
BCP9000297,
CS-1410,
DB00701,
MCULE-8147835017,
MP-1964,
SB19589,
(3S)-tetrahydro-3-furyl N-[(1S,2R)-3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxy-propyl]carbamate,
4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide,
AJ-45667,
AS-30915,
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA),
CC-24109,
HY-17430,
SC-14018,
SMR003885056,
141w94, kvx-478, agenerase, prozei,,
BCP0726000051,
AB0008692,
AB2000184,
AX8041340,
LS-173559,
ST2419097,
FT-0082731,
FT-0602842,
SW219687-1,
A11985,
C08086,
D00894,
24228-EP2272516A2,
24228-EP2298761A1,
24228-EP2298783A1,
24228-EP2314590A1,
AB01275534-01,
AB01275534_02,
814A499,
A810295,
C-22976,
SR-05000001530,
SR-05000001530-1,
Z1557399789,
(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate,
(3S)-tetrahydrofuran-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]carbamate,
(3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate,
[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-oxidanyl-1-phenyl-butan-2-yl]carbamate,
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin( HHA),
Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester,
Carbamic acid,[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-,(3S)-tetrahydro-3-furanyl ester,
N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamic acid [(3S)-3-oxolanyl] ester,
samprenavir,
D0A0OO,
Amprenavir, 98% - 5mg 5mg,
CID65016,
C25-H35-N3-O6-S,
CB10251,
CS-O-11599,
A8201,
C095108,
APV,
AMP,
(S)-tetrahydrofuran-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate,
Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin(HHA),
Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester,